✦ LIBER ✦

Unpredictability of Intravenous Busulfan Pharmacokinetics in Children Undergoing Hematopoietic Stem Cell Transplantation for Advanced Beta Thalassemia: Limited Toxicity with a Dose-Adjustment Policy

✍ Scribed by Robert Chiesa; Barbara Cappelli; Roberto Crocchiolo; Ilaria Frugnoli; Erika Biral; Anna Noè; Costanza Evangelio; Marco Fossati; Tito Roccia; Alessandra Biffi; Valentina Finizio; Alessandro Aiuti; Monica Broglia; Antonella Bartoli; Fabio Ciceri; Maria Grazia Roncarolo; Sarah Marktel

Book ID: 116281236
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 310 KB
Volume: 16
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2009.11.024

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics and individualized dose

Pharmacokinetics and individualized dose adjustment of intravenous busulfan in children with advanced hematologic malignancies undergoing allogeneic stem cell transplantation

✍ Hai Tran; Demetrios Petropoulos; Laura Worth; Craig A. Mullen; Timothy Madden; B 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 125 KB

Pharmacokinetics of a Test Dose of Intra

Pharmacokinetics of a Test Dose of Intravenous Busulfan Guide Dose Modifications to Achieve an Optimal Area Under the Curve of a Single Daily Dose of Intravenous Busulfan in Children Undergoing a Reduced-Intensity Conditioning Regimen with Hematopoietic Stem Cell Transplantation

✍ Morris Kletzel; David Jacobsohn; Reggie Duerst 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 194 KB

Pharmacokinetic-Directed Dose Adjustment

Pharmacokinetic-Directed Dose Adjustment Is Essential for Intravenous Busulfan Exposure Optimization: Findings From a Multi-Center Phase II Study of Autologous Hematopoietic Stem Cell Transplantation for Lymphoma in North America

✍ Lill, Michael; Costa, Luciano J.; Yeh, Rosa F.; Lim, Stephen; Stuart, Robert; Wa 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 60 KB

229: Twice-Daily Intravenous (IV) Busulf

229: Twice-Daily Intravenous (IV) Busulfan (Bu) x 4 Days in Children Undergoing a Reduced-Intensity Conditioning (RIC) Regimen with Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT) is Safe and Well-Tolerated but Results in Significantly Increased Bu Clearance (CL) and Decreased Area Under the Curve (AUC) and Half-Life (t1/2) When Compared to IV Bu Twice-Daily Dosing Pharmacokinetics (PK) in Adults

✍ I. Waxman; M. Bhatia; M. Milone; L.M. Shaw; L. Baldinger; O. Militano; J. Garvin 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 60 KB